Advertisement

Related Videos

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Amit Sanyal, MD: A Clinician’s Perspective

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Jan
08
Today In Oncology
Using AI to Ensure That All Patients With Cancer Have Access to Precision Oncology Care
AI Enhances Detection of Missed Breast Cancers on Screening Tomosynthesis
Hybrid AI Approach With Uncertainty Quantification for Mammography Reading Supports Safe Workload Reduction
AI May Boost Efficacy of Cancer Care but Physicians Remain Critical to Decision Making
Novel AI Platform May Help Identify Patients Likely to Benefit Most From Clinical Trials
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo